Advertisement

Contact
searchSearch
HMP Global

ADVERTISEMENT

Interviews

Anant Ramaswamy, MD, Tata Memorial Hospital
Videos
Addition of Docetaxel to FOLFOX/CAPOX Backbone Fails to Improve OS in Advanced GEJ/Gastric Cancer
01/20/2024

Featuring Anant Ramaswamy, MD

Featuring Anant Ramaswamy, MD
Anant Ramaswamy, MD, discusses results from the phase 3 DOC-GC study which explored the efficacy of docetaxel added to a FOLFOX/CAPOX backbone for patients with advanced GEJ and gastric cancers.
Anant Ramaswamy, MD, discusses results from the phase 3 DOC-GC study which explored the efficacy of docetaxel added to a FOLFOX/CAPOX backbone for patients with advanced GEJ and gastric cancers.
Anant Ramaswamy, MD, discusses...
01/20/2024
Oncology
Yelena Janjigian, MD, Memorial Sloan Kettering Cancer Center
Videos
Global Treatment of Gastric/GEJ Cancer with Durvalumab Plus FLOT
01/19/2024

Featuring Yelena Janjigian, MD

Featuring Yelena Janjigian, MD ...
Yelena Janjigian, MD, discussed the recent subgroup analysis from the MATTERHORN study, evaluating durvalumab plus FLOT for patients with gastric or gastroesophageal junction cancer.
Yelena Janjigian, MD, discussed the recent subgroup analysis from the MATTERHORN study, evaluating durvalumab plus FLOT for patients with gastric or gastroesophageal junction cancer.
Yelena Janjigian, MD, discussed...
01/19/2024
Oncology

Advertisement

Live From Expo 2023: Peter Antevy and Charlie Coyle on the Wall Time Problem
Podcasts
Live From Expo 2023: Peter Antevy and Charlie Coyle on the Wall Time Problem
10/27/2023

Guests: Charlie Coyle and Dr. Peter Antevy

Guests: Charlie Coyle and Dr. Peter A...
In this episode direct from the exhibit hall floor, Mike McCabe sits down with two esteemed friends—Chief Charlie Coyle and Dr. Peter Antevy from Florida—for a hard-hitting discussion on "wall time" in EMS.
In this episode direct from the exhibit hall floor, Mike McCabe sits down with two esteemed friends—Chief Charlie Coyle and Dr. Peter Antevy from Florida—for a hard-hitting discussion on "wall time" in EMS.
In this episode direct from the...
10/27/2023
EMSWorld
Windy Cole, DPM
Podcasts
Pain and the Journey of the Chronic Wound Patient
10/27/2023
Windy Cole, DPM, CWSP, FACCWS
Dr. Cole delves into pain management and its role in the chronic wound patient's journey. She also addresses a novel option from her experience and in the literature.
Dr. Cole delves into pain management and its role in the chronic wound patient's journey. She also addresses a novel option from her experience and in the literature.
Dr. Cole delves into pain...
10/27/2023
Podiatry Today
Dr. Nair and Schloss
Podcasts
Innovation and Passion in Electrophysiology: Interview With Devi Nair, MD
10/23/2023

Podcast discussion edited by Jodie Elrod

Podcast discussion edited by Jodie El...
In this episode of The EP Edit podcast, we feature a discussion between Devi Nair, MD, and Edward J Schloss, MD. Dr Schloss talks with Dr Nair about her long and successful career in cardiac electrophysiology (EP).
In this episode of The EP Edit podcast, we feature a discussion between Devi Nair, MD, and Edward J Schloss, MD. Dr Schloss talks with Dr Nair about her long and successful career in cardiac electrophysiology (EP).
In this episode of The EP Edit...
10/23/2023
EP Lab Digest

Advertisement

Bradley Monk, MD, University of Arizona School of Medicine
Videos
Mirvetuximab Soravtansine for Folate Receptor-Alpha High, Platinum-Resistant Ovarian Cancer
08/02/2023

Featuring Bradley J. Monk, MD

Featuring Bradley J. Monk, MD
Bradley Monk, MD, discusses the results from the phase 3 MIRASOL trial and shares insights about mirvetuximab soravtansine for folate receptor-alpha high, platinum-resistant ovarian cancer.
Bradley Monk, MD, discusses the results from the phase 3 MIRASOL trial and shares insights about mirvetuximab soravtansine for folate receptor-alpha high, platinum-resistant ovarian cancer.
Bradley Monk, MD, discusses the...
08/02/2023
Oncology
Lucjan Wyrwicz, MD, Maria Sklodowska Curie National Cancer Research Institute
Videos
Continued Benefit From Pembrolizumab Plus Chemotherapy in Later-Line Therapy for Patients With Advanced, HER2-Negative Gastric/Gastroesophageal Junction Adenocarcinoma
07/12/2023

Featuring Lucjan Wyrwicz, MD

Featuring Lucjan Wyrwicz, MD
At the 2023 World Congress on Gastrointestinal Cancers, Lucjan Wyrwicz discusses the extended benefit of pembrolizumab plus chemotherapy when evaluating outcomes on next-line therapy for advanced HER2-negative, gastric/gastroesophageal...
At the 2023 World Congress on Gastrointestinal Cancers, Lucjan Wyrwicz discusses the extended benefit of pembrolizumab plus chemotherapy when evaluating outcomes on next-line therapy for advanced HER2-negative, gastric/gastroesophageal...
At the 2023 World Congress on...
07/12/2023
Oncology
James Harding, MD, Memorial Sloan Kettering Cancer Center
Videos
Novel Dual IDH-Inhibitor Plus Chemotherapy Showed Promising Efficacy, Safety for Patients With Advanced IDH-Mutant Cholangiocarcinoma
07/12/2023

Featuring James Harding, MD

Featuring James Harding, MD
According to a study presented at the 2023 World Congress on Gastrointestinal Cancers, the IDH1/2-inhibitor LY3410738 showed promising efficacy and safety in combination with chemotherapy for patients with locally advanced or metastatic...
According to a study presented at the 2023 World Congress on Gastrointestinal Cancers, the IDH1/2-inhibitor LY3410738 showed promising efficacy and safety in combination with chemotherapy for patients with locally advanced or metastatic...
According to a study presented...
07/12/2023
Oncology

Advertisement

Javier Cortes, MD, PhD, International Breast Cancer Center, Madrid, Spain
Videos
Chemotherapy De-escalation for HER2-Positive Early Breast Cancer
06/21/2023
Javier Cortes, MD, PhD, discusses results from the PHERGain study, evaluating chemotherapy de-escalation strategies in HER2-positive early breast cancer, presented at the 2023 ASCO Annual Meeting.
Javier Cortes, MD, PhD, discusses results from the PHERGain study, evaluating chemotherapy de-escalation strategies in HER2-positive early breast cancer, presented at the 2023 ASCO Annual Meeting.
Javier Cortes, MD, PhD,...
06/21/2023
Oncology
Lars Henrik Jensen, MD, University Hospital of Southern Denmark
Videos
Neoadjuvant Chemotherapy for Locally Advanced Colorectal Cancer
06/14/2023
On site at ASCO 2023, Dr Lars Henrik Jensen shares results from the phase 3 NeoCol trial evaluating the addition of neoadjuvant chemotherapy to initial surgery for patients with locally advanced colon cancer.
On site at ASCO 2023, Dr Lars Henrik Jensen shares results from the phase 3 NeoCol trial evaluating the addition of neoadjuvant chemotherapy to initial surgery for patients with locally advanced colon cancer.
On site at ASCO 2023, Dr Lars...
06/14/2023
Oncology

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 18 ⁠–⁠ September 20
September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
See Full Calendar

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use